ArticleNature cancer2025

Targeting both death and paracaspase domains of MALT1 with antisense oligonucleotides overcomes resistance to immune-checkpoint inhibitors.

Yuwei Tao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.